Cite
HARVARD Citation
Faiena, I. et al. (n.d.). A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma. Journal of immunotherapy. 43 (9), p. . [Online].